Gianfranco Pagano

University of Palermo — Italy

Medicine · Health Sciences

45h-index10.2kcitations227works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(55), Diabetes Management and Research(35), Liver Disease Diagnosis and Treatment(34), Diabetes and associated disorders(27), Lipoproteins and Cardiovascular Health(24)

Publications223 total

Clinical remission with biologics in severe asthmatics is not affected by age
2025
Effects of a nutraceutical combination in patients with chronic lumbosacral radicular pain.
PubMed·2019· 1 cited
Fasting Hepatic Glucose Production and Its Suppression during Hyperinsulinemia in Different Insulin-Resistant States1
Frontiers in diabetes·2015
Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure
European Heart Journal·2013· 1 citedOpen Access
Loxin polymorphism is associated with increased resistin levels and with oxidative status
Clinical Biochemistry·2011· 2 cited
A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
Annals of Medicine·2011· 282 citedOpen Access
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Annals of Medicine·2010· 1.3k cited
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Hepatology·2010· 562 cited
Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients C-reactive protein in type 2 diabetic patients
Cardiovascular Diabetology·2010· 14 citedOpen Access
[45] POTENTIAL PROGNOSTIC VALUE OF TCL7L2 POLYMORPHISM IN THE PREDICTION OF IMPAIRED FASTING GLUCOSE AND DIABETES
Nutrition Metabolism and Cardiovascular Diseases·2009
Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
American Journal of Clinical Nutrition·2009· 25 cited
Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
Journal of Gastroenterology·2009· 20 cited
Transcription Factor 7-Like 2 (<i>TCF7L2</i>) Polymorphism and Hyperglycemia in an Adult Italian Population-Based Cohort
Diabetes Care·2009· 16 citedOpen Access
Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers
Nutrition Metabolism and Cardiovascular Diseases·2008· 28 cited
High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study
Journal of Hypertension·2008· 35 cited
Phytosterol‐Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia
Lipids·2008· 29 cited
Transcription factor 7–like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH #
Hepatology·2008· 87 citedOpen Access
Diet or exercise: what is more effective in preventing or reducing metabolic alterations?
European Journal of Endocrinology·2008· 44 cited
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction
Journal of Endocrinological Investigation·2008· 42 cited
Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat
Hepatology·2008· 134 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Maurizio Cassader(29), Roberto Gambino(22), P. Cavallo‐Perin(21), Giovanni Musso(13), Simona Bo(12), Marilena Durazzo(11), Graziella Bruno(10), Franco Merletti(9), G Bargero(8), Giovanni Pacini(6), Annibale Biggeri(6), Luigi Gentile(6), Franco De Michieli(5), Giampaolo Biroli(4), Mario Rizzetto(3), Monica Carello(3), Alberto Bruno(3), Stefania Ferrero(3), Giovannino Ciccone(3), Guido Menato(3)